BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31873741)

  • 1. Constitutive expression of the cryptic vanGCd operon promotes vancomycin resistance in Clostridioides difficile clinical isolates.
    Shen WJ; Deshpande A; Hevener KE; Endres BT; Garey KW; Palmer KL; Hurdle JG
    J Antimicrob Chemother; 2020 Apr; 75(4):859-867. PubMed ID: 31873741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The functional vanGCd cluster of Clostridium difficile does not confer vancomycin resistance.
    Ammam F; Meziane-Cherif D; Mengin-Lecreulx D; Blanot D; Patin D; Boneca IG; Courvalin P; Lambert T; Candela T
    Mol Microbiol; 2013 Aug; 89(4):612-25. PubMed ID: 23782343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VanG- and D-Ala-D-Ser-dependent peptidoglycan synthesis and vancomycin resistance in Clostridioides difficile.
    Belitsky BR
    Mol Microbiol; 2022 Nov; 118(5):526-540. PubMed ID: 36065735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The
    Wickramage I; Peng Z; Chakraborty S; Harmanus C; Kuijper EJ; Alrabaa S; Smits WK; Sun X
    Microbiol Spectr; 2023 Jun; 11(3):e0377722. PubMed ID: 37125917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histidine kinase-mediated cross-regulation of the vancomycin-resistance operon in Clostridioides difficile.
    Belitsky BR
    Mol Microbiol; 2024 Jun; 121(6):1182-1199. PubMed ID: 38690761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AsnB is responsible for peptidoglycan precursor amidation in
    Ammam F; Patin D; Coullon H; Blanot D; Lambert T; Mengin-Lecreulx D; Candela T
    Microbiology (Reading); 2020 Jun; 166(6):567-578. PubMed ID: 32375990
    [No Abstract]   [Full Text] [Related]  

  • 7. Genomic and expression analysis of the vanG-like gene cluster of Clostridium difficile.
    Peltier J; Courtin P; El Meouche I; Catel-Ferreira M; Chapot-Chartier MP; Lemée L; Pons JL
    Microbiology (Reading); 2013 Jul; 159(Pt 7):1510-1520. PubMed ID: 23676437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic characterization of a VanG-type vancomycin-resistant Enterococcus faecium clinical isolate.
    Sassi M; Guérin F; Lesec L; Isnard C; Fines-Guyon M; Cattoir V; Giard JC
    J Antimicrob Chemother; 2018 Apr; 73(4):852-855. PubMed ID: 29346643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility of Clostridioides difficile isolated from diarrhoeal stool specimens of Canadian patients: summary of results from the Canadian Clostridioides difficile (CAN-DIFF) surveillance study from 2013 to 2017.
    Karlowsky JA; Adam HJ; Baxter MR; Dutka CW; Nichol KA; Laing NM; Golding GR; Zhanel GG
    J Antimicrob Chemother; 2020 Jul; 75(7):1824-1832. PubMed ID: 32294172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An operon encoding enzymes for synthesis of a putative extracellular carbohydrate attenuates acquired vancomycin resistance in Streptomyces coelicolor.
    Read N; Howlett R; Smith MCM
    Microbiology (Reading); 2019 Feb; 165(2):208-223. PubMed ID: 30632959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the
    G C B; Sahukhal GS; Elasri MO
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31307991
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro activity of eravacycline against common ribotypes of Clostridioides difficile.
    Bassères E; Begum K; Lancaster C; Gonzales-Luna AJ; Carlson TJ; Miranda J; Rashid T; Alam MJ; Eyre DW; Wilcox MH; Garey KW
    J Antimicrob Chemother; 2020 Oct; 75(10):2879-2884. PubMed ID: 32719870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High sporulation and overexpression of virulence factors in biofilms and reduced susceptibility to vancomycin and linezolid in recurrent Clostridium [Clostridioides] difficile infection isolates.
    Tijerina-Rodríguez L; Villarreal-Treviño L; Baines SD; Morfín-Otero R; Camacho-Ortíz A; Flores-Treviño S; Maldonado-Garza H; Rodríguez-Noriega E; Garza-González E
    PLoS One; 2019; 14(7):e0220671. PubMed ID: 31365590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin-dependent Enterococcus faecalis clinical isolates and revertant mutants.
    Van Bambeke F; Chauvel M; Reynolds PE; Fraimow HS; Courvalin P
    Antimicrob Agents Chemother; 1999 Jan; 43(1):41-7. PubMed ID: 9869563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VanG-type vancomycin-resistant Enterococcus faecalis strains isolated in Canada.
    Boyd DA; Du T; Hizon R; Kaplen B; Murphy T; Tyler S; Brown S; Jamieson F; Weiss K; Mulvey MR
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2217-21. PubMed ID: 16723588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of berberine chloride and/or its combination with vancomycin on the growth, biofilm formation, and motility of Clostridioides difficile.
    Wultańska D; Piotrowski M; Pituch H
    Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1391-1399. PubMed ID: 32140903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in Clostridium (Clostridioides) difficile PCR-Ribotype Distribution and Antimicrobial Resistance in a German Tertiary Care Hospital Over the Last 10 Years.
    Piepenbrock E; Stelzer Y; Berger F; Jazmati N
    Curr Microbiol; 2019 Apr; 76(4):520-526. PubMed ID: 30805700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of vancomycin resistance.
    Stogios PJ; Savchenko A
    Protein Sci; 2020 Mar; 29(3):654-669. PubMed ID: 31899563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transferable vancomycin resistance in clade B commensal-type Enterococcus faecium.
    Lebreton F; Valentino MD; Schaufler K; Earl AM; Cattoir V; Gilmore MS
    J Antimicrob Chemother; 2018 Jun; 73(6):1479-1486. PubMed ID: 29462403
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Begum K; Bassères E; Miranda J; Lancaster C; Gonzales-Luna AJ; Carlson TJ; Rashid T; Eyre DW; Wilcox MH; Alam MJ; Garey KW
    Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32513796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.